Dysautonomia
30
7
9
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.3%
1 terminated out of 30 trials
92.9%
+6.4% vs benchmark
0%
0 trials in Phase 3/4
8%
1 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (30)
Blood Pressure Effects on Cognition and Brain Blood Flow in PD
Neuro-Emotional Release: Veins and Endocrine System (NERVE) Therapy for Children With Dysautonomia
Data Collection of Standard Care of Patients in the EMG Section
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
Non-invasive Vagus Nerve Stimulation for Chronic Musculoskeletal Pain
Autonomic Reactivity and Personalized Neurostimulation
Pathophysiology of Dysautonomia and Postural Tachycardia Syndrome (POTS) in Post-viral Syndromes and COVID-19
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Screening for Alterations in the Autonomic Nervous System
Diagnostic Accuracy of The Water Immersion Wrinkle Test for Small Fiber Neuropathy
The Long COVID-19 Wearable Device Study
Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
VNS for Long-COVID-19
Effects of Osteopathic Technique on Autonomic Nervous System Activity
Mindfulness in Post Acute Sequelae of SARS-CoV-2 Infection (PASC) Dysautonomia
Dysautonomia and Systemic Interactions in Traumatic Brain Injury
Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life
Concentration and Attentional Deficits in POTS and Other Autonomic Neuropathies
Physiotherapy for Persistent Function by Superficial Neuromodulation
Post Covid-19 Dysautonomia Rehabilitation Randomized Controlled Trial